# China NMPA Product Recall - Intra-Aortic Occlusion Device

Source: https://www.globalkeysolutions.net/records/china_product_recall/edwards-lifesciences-llc/accb9387-12d4-4469-a572-f3b57a5ef84d/
Source feed: China

> China NMPA product recall for Intra-Aortic Occlusion Device by Edwards Lifesciences LLC published August 09, 2019. Recall level: Level 1 Recall. The National Medical Products Administration (NMPA) issued an announcement on August 9, 2019, detail

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Edwards Lifesciences LLC's Changes in the Batch Scope and Corrective Actions for the Intra-Aortic Occlusion Device Recall
- Company Name: Edwards Lifesciences LLC
- Publication Date: 2019-08-09
- Product Name: Intra-Aortic Occlusion Device
- Recall Level: Level 1 Recall
- Recall Reason: The products in question may have a problem where some batches of catheter balloons rupture during use.
- Discovering Company: Edwards (Shanghai) Medical Supplies Co., Ltd.
- Manufacturing Company: Edwards Lifesciences LLC
- Summary: The National Medical Products Administration (NMPA) issued an announcement on August 9, 2019, detailing a significant voluntary product recall by Edwards Lifesciences LLC. This high-priority Class I recall, initially disclosed on May 23, 2019, pertains to their Intra-Aortic Occlusion Device, registered under Certificate No.: 20183132601. The critical safety concern stems from a potential design or manufacturing flaw where the balloon component of the catheter in specific product batches may rupture during clinical use. Such an occurrence presents a serious risk to patient health, necessitating the highest level of recall classification. Edwards Lifesciences LLC, as the manufacturer, has proactively initiated the recall and is undertaking corrective actions to address this defect. The scope of the recall has been subsequently updated to encompass all affected models, specifications, and batch numbers, which are comprehensively detailed in the official "Medical Device Recall Event Report Form." This regulatory action underscores the NMPA's commitment to overseeing medical device safety and ensuring manufacturers comply with stringent quality and post-market surveillance requirements within the Chinese market.

Company: https://www.globalkeysolutions.net/companies/edwards-lifesciences-llc/d78876e8-6a4a-49b4-8cb5-30579a7ed097/